EUVIMEDEUVIMED entdecken
Open Access

DOT1L is a barrier to histone acetylation during reprogramming to pluripotency

Coral K Wille iD, Xiaoya Zhang iD, Spencer A Haws iD, John M Denu, Rupa Sridharan iD

Science Advances · 17.11.2023 · 9 (46)

DOI: 10.1126/sciadv.adf3980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 17.11.2023. Verfasst von Coral K Wille und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA. Hauptthemen laut MEDLINE: Histones, Chromatin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Embryonic stem cells (ESCs) have transcriptionally permissive chromatin enriched for gene activation–associated histone modifications. A striking exception is DOT1L-mediated H3K79 dimethylation (H3K79me2) that is considered a positive regulator of transcription. We find that ESCs are depleted for H3K79me2 at shared locations of enrichment with somatic cells, which are highly and ubiquitously expressed housekeeping genes, and have lower RNA polymerase II (RNAPII) at the transcription start site (TSS) despite greater nascent transcription. Inhibiting DOT1L increases the efficiency of reprogramming of somatic to induced pluripotent stem cells, enables an ESC-like RNAPII pattern at the TSS, and functionally compensates for enforced RNAPII pausing. DOT1L inhibition increases H3K27 methylation and RNAPII elongation–enhancing histone acetylation without changing the expression of the causal histone-modifying enzymes. Only the maintenance of elevated histone acetylation is essential for enhanced reprogramming and occurs at loci that are depleted for H3K79me2. Thus, DOT1L inhibition promotes the hyperacetylation and hypertranscription pluripotent properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesChromatinAcetylationCell DifferentiationTranscription, GeneticRNA Polymerase II

Substanzen

HistonesChromatinRNA Polymerase II

Autor:innen und Institutionen

  • Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA.
  • Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706, USA.
  • Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
  • Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI 53705, USA.

ORCID-Profile: Coral K Wille, Xiaoya Zhang, Spencer A Haws, Rupa Sridharan

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Wille, C. K., Zhang, X., Haws, S. A., Denu, J. M., & Sridharan, R. (2023). DOT1L is a barrier to histone acetylation during reprogramming to pluripotency. Science Advances, 9(46). https://doi.org/10.1126/sciadv.adf3980

Vancouver

Wille CK, Zhang X, Haws SA, Denu JM, Sridharan R. DOT1L is a barrier to histone acetylation during reprogramming to pluripotency. Science Advances. 2023;9(46). doi:10.1126/sciadv.adf3980

BibTeX
@article{Wille2023,
  author = {Wille, Coral K and Zhang, Xiaoya and Haws, Spencer A and Denu, John M and Sridharan, Rupa},
  title = {DOT1L is a barrier to histone acetylation during reprogramming to pluripotency},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {46},
  doi = {10.1126/sciadv.adf3980}
}
Kostenlos starten →